Global Alpha Emitters Market: Industry Analysis & Forecast 2020-2026, By Type of Radionuclide, Application and Region.

Global Alpha Emitters Market is expected to reach US$ 4.5 Bn. at a CAGR of 36 during the forecast period 2026. Targeted Alpha Therapy (TAT) employing alpha particle emitters is such a new approach to cancer treatment. International Atomic Energy Agency (IAEA) is making a large investment in the design and development of target-specific radiopharmaceuticals. The report covers the current estimated and forecasted data for the Global Alpha Emitters Market on a global and regional level. The report provides an in-depth analysis of the Global Alpha Emitters Market for the period 2019 – 2026, wherein 2019 is the base year and the period from 2020 to 2026 is the forecast period. Data for 2016- 2018 has been included as historical information. The study provides a detailed perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ Mn), across the different geographies, which include North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM). The Global Alpha Emitters Market is segmented by Radionuclide type, Application and Region. The report provides qualitative and quantitative insights on the alpha emitter’s industry trends and a detailed analysis of the market size and growth rate of all segments in the market.

Global Alpha Emitters Market Key Players

Bayer AG, IBA Radiopharma Solution, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc., RadioMedix Inc., Telix Pharmaceuticals Ltd, Fusion Pharmaceuticals, SHINE medical technologies, Isotopia Molecular Imaging Limited, Global Medical Solutions.

Global Alpha Emitters Market Dynamics

Cancer therapy with alpha-particle emitters is surely one of the most demanding multidisciplinary endeavours. Alpha emitters achieve the desired biodistribution and associated dose distribution necessary for successful therapy with acceptable acute and long-term toxicities. An increase in awareness among cancer patients about alpha emitter therapy is the driving factor of the global market. A large scope of clinical development in radiotherapy is generating lucrative opportunity for the global market. Nontargeted healthy cells are damaged, via radiation-induced death or stress of neighbouring cells. This is the disadvantage of alpha emitters’ therapy and restraining factor of the global market.

Global Alpha Emitters Market Segment Analysis

 Global Alpha Emitters Market size was valued at USD xx million in 2019 and is expected to reach US $ xx million by 2026, at a CAGR of 22% during a forecast period. Targeted Alpha Therapy (TAT) employing alpha particle emitters is such a new approach to cancer treatment. International Atomic Energy Agency (IAEA) is making a large investment in the design and development of target-specific radiopharmaceuticals. The report covers the current estimated and forecasted data for the Global Alpha Emitters Market on a global and regional level. The report provides an in-depth analysis of the Global Alpha Emitters Market for the period 2019 – 2026, wherein 2019 is the base year and the period from 2020 to 2026 is the forecast period. Data for 2016- 2018 has been included as historical information. The study provides a detailed perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ Mn), across the different geographies, which include North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM). The Global Alpha Emitters Market is segmented by Radionuclide type, Application and Region. The report provides qualitative and quantitative insights on the alpha emitter’s industry trends and a detailed analysis of the market size and growth rate of all segments in the market. Global Alpha Emitters Market Key Players Bayer AG, IBA Radiopharma Solution, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc., RadioMedix Inc., Telix Pharmaceuticals Ltd, Fusion Pharmaceuticals, SHINE medical technologies, Isotopia Molecular Imaging Limited, Global Medical Solutions. Global Alpha Emitters Market Dynamics Cancer therapy with alpha-particle emitters is surely one of the most demanding multidisciplinary endeavours. Alpha emitters achieve the desired biodistribution and associated dose distribution necessary for successful therapy with acceptable acute and long-term toxicities. An increase in awareness among cancer patients about alpha emitter therapy is the driving factor of the global market. A large scope of clinical development in radiotherapy is generating lucrative opportunity for the global market. Nontargeted healthy cells are damaged, via radiation-induced death or stress of neighbouring cells. This is the disadvantage of alpha emitters’ therapy and restraining factor of the global market. Global Alpha Emitters Market Segment Analysis The radium segment is expected to commend the largest market share of XX% by 2026. Radium radionuclide is the medically relevant and currently readily available potential therapeutic applications. Hence, the radium segment has an XX% market share in the global market. High research & development expenditure and continuous efforts to find out alpha emitters applications in oncology are propelling the growth of the global market. Ongoing research activities on radium radionuclide provide significant opportunities for the growth of the global market. The ovarian cancer segment is projected to commend the largest market share of xx% by 2026. Radionuclides treatment is employed for both diagnosis and therapy of several types of cancers. Alpha-Emitting radionuclides may be an effective alternative treatment against ovarian carcinoma. More than 3.0 million people are newly diagnosed with cancer each year and undergoing Targeted Alpha Therapy. Many epidemiological studies on ovarian carcinoma were conducted in Europe and North America, showing the positive outcomes of the alpha emitter’s therapy. Global Alpha Emitters Market Regional Analysis The Europe region has shown the largest growth opportunity for the global market in 2019 and may maintain its dominance in the forecast period. Cancer is the second cause of death and morbidity in Europe. Unfortunately, currently available treatments cannot permanently cure most cancers. This creates wide opportunities for the global market in the forecast period. The objective of the report is to present a comprehensive analysis of the global alpha emitters market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global alpha emitters market dynamics, structure by analyzing the market segments and project the global alpha emitters market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global alpha emitters market make the report investor’s guide. Global Alpha Emitters Market Scope Global Alpha Emitters Market, by Region • North America • Europe • Asia Pacific • Middle East & Africa • South America Global Alpha Emitters Market Key Players • Bayer AG • IBA Radiopharma Solution • Alpha Tau Medical Ltd • Actinium Pharmaceutical Inc. • RadioMedix Inc. • Telix Pharmaceuticals Ltd • Fusion Pharmaceuticals • SHINE medical technologies • Isotopia Molecular Imaging Limitd • Global Medical Solutions To know about the Research Methodology :- Request Free Sample Report The radium segment is expected to commend the largest market share of XX% by 2026. Radium radionuclide is the medically relevant and currently readily available potential therapeutic applications. Hence, the radium segment has an XX% market share in the global market. High research & development expenditure and continuous efforts to find out alpha emitters applications in oncology are propelling the growth of the global market. Ongoing research activities on radium radionuclide provide significant opportunities for the growth of the global market. The ovarian cancer segment is projected to commend the largest market share of xx% by 2026. Radionuclides treatment is employed for both diagnosis and therapy of several types of cancers. Alpha-Emitting radionuclides may be an effective alternative treatment against ovarian carcinoma. More than 3.0 million people are newly diagnosed with cancer each year and undergoing Targeted Alpha Therapy. Many epidemiological studies on ovarian carcinoma were conducted in Europe and North America, showing the positive outcomes of the alpha emitter’s therapy.

Global Alpha Emitters Market Regional Analysis

Global Alpha Emitters Market The Europe region has shown the largest growth opportunity for the global market in 2019 and may maintain its dominance in the forecast period. Cancer is the second cause of death and morbidity in Europe. Unfortunately, currently available treatments cannot permanently cure most cancers. This creates wide opportunities for the global market in the forecast period. The objective of the report is to present a comprehensive analysis of the global alpha emitters market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global alpha emitters market dynamics, structure by analyzing the market segments and project the global alpha emitters market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global alpha emitters market make the report investor’s guide.

Global Alpha Emitters Market Scope: Inquire before buying

Global Alpha Emitters Market

Global Alpha Emitters Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Global Alpha Emitters Market Key Players

• Bayer AG • IBA Radiopharma Solution • Alpha Tau Medical Ltd • Actinium Pharmaceutical Inc. • RadioMedix Inc. • Telix Pharmaceuticals Ltd • Fusion Pharmaceuticals • SHINE medical technologies • Isotopia Molecular Imaging Limitd • Global Medical Solutions
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Alpha Emitters Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Alpha Emitters Market 3.4. Geographical Snapshot of the Alpha Emitters Market, By Manufacturer share 4. Global Alpha Emitters Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Alpha Emitters Market 5. Supply Side and Demand Side Indicators 6. Global Alpha Emitters Market Analysis and Forecast, 2019-2026 6.1. Global Alpha Emitters Market Size & Y-o-Y Growth Analysis. 7. Global Alpha Emitters Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 7.1.1. Radium 7.1.2. Bismuth 7.1.3. Lead 7.1.4. Actinium 7.1.5. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Ovarian cancer 7.2.2. Pancreatic Cancer 7.2.3. Lymphoma 7.2.4. Melanoma 7.2.5. Bone Metastasis 7.2.6. Others 8. Global Alpha Emitters Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Alpha Emitters Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 9.1.1. Radium 9.1.2. Bismuth 9.1.3. Lead 9.1.4. Actinium 9.1.5. Others 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Ovarian cancer 9.2.2. Pancreatic Cancer 9.2.3. Lymphoma 9.2.4. Melanoma 9.2.5. Bone Metastasis 9.2.6. Others 10. North America Alpha Emitters Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Alpha Emitters Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12. Canada Alpha Emitters Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13. Mexico Alpha Emitters Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14. Europe Alpha Emitters Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 15. Europe Alpha Emitters Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Alpha Emitters Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17. France Alpha Emitters Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18. Germany Alpha Emitters Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19. Italy Alpha Emitters Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20. Spain Alpha Emitters Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21. Sweden Alpha Emitters Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22. CIS Countries Alpha Emitters Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23. Rest of Europe Alpha Emitters Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24. Asia Pacific Alpha Emitters Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 25. Asia Pacific Alpha Emitters Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Alpha Emitters Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27. India Alpha Emitters Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28. Japan Alpha Emitters Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29. South Korea Alpha Emitters Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30. Australia Alpha Emitters Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31. ASEAN Alpha Emitters Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32. Rest of Asia Pacific Alpha Emitters Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33. Middle East Africa Alpha Emitters Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 34. Middle East Africa Alpha Emitters Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Alpha Emitters Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36. GCC Countries Alpha Emitters Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37. Egypt Alpha Emitters Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38. Nigeria Alpha Emitters Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39. Rest of ME&A Alpha Emitters Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40. South America Alpha Emitters Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 41. South America Alpha Emitters Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Alpha Emitters Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43. Argentina Alpha Emitters Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44. Rest of South America Alpha Emitters Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Type of Radionuclide, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Alpha Emitters Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1.1. Bayer AG 45.3.1.2. Company Overview 45.3.1.3. Financial Overview 45.3.1.4. Geographic Footprint 45.3.1.5. Product Portfolio 45.3.1.6. Business Strategy 45.3.1.7. Recent Developments 45.3.2. IBA Radiopharma Solution 45.3.3. Alpha Tau Medical Ltd 45.3.4. Actinium Pharmaceutical Inc. 45.3.5. RadioMedix Inc. 45.3.6. Telix Pharmaceuticals Ltd 45.3.7. Fusion Pharmaceuticals 45.3.8. SHINE medical technologies 45.3.9. Isotopia Molecular Imaging Limitd 45.3.10. Global Medical Solutions 46. Primary Key Insights

About This Report

Report ID 92700
Category Healthcare
Published Date April 2021
Updated Date Nov 2021
Contact Us